Predict your next investment

HEALTHCARE
biogenex.com

See what CB Insights has to offer

Stage

Other Investors | Alive

About BioGenex

BioGenex offers affordable healthcare solutions for improved wellness of humanity. The company is a technology provider in Molecular Pathology and provides total solution for the complete automation of cell and tissue testing. Through its technologies, it enables disease diagnosis at molecular level. Diagnosis at the molecular level (primarily targeting DNA, RNA and protein), affords early and preventive diagnosis of genetic and infectious diseases.

BioGenex Headquarter Location

49026 Milmont Drive

Fremont, California, 94538,

United States

510-824-1400

Latest BioGenex News

Monoclonal Antibody Diagnostic Reagents Market Booming Worldwide, Top Manufacturers: AnaSpec, BioGenex, Bio-Rad, Biocare Medical, BioVision, Celltrion

Aug 17, 2021

Search jobs 17-Aug-2021 Monoclonal Antibody Diagnostic Reagents Market Booming Worldwide, Top Manufacturers: AnaSpec, BioGenex, Bio-Rad, Biocare Medical, BioVision, Celltrion The “Monoclonal Antibody Diagnostic Reagents Market” report provides a quick description about market status, size, companies share, growth, opportunities and upcoming trends. This report includes the corporate profile, values that the challenges and drivers & restraints that have a serious impact on the industry analysis. The information within the report that help form the longer term projections during the forecast year. The up so far analysis to assists in understanding of the changing competitive analysis. Additionally, the market strategies including moderate growth during the years. The research on Monoclonal Antibody Diagnostic Reagents market scenario which will affect the overview the forecast period, including as opportunities, prime challenges, and current/future trends. To supply an in-depth analysis of all Monoclonal Antibody Diagnostic Reagents regions included within the report into sections to supply a comprehensive competitive analysis. Some of the leading manufacturers and suppliers of the Monoclonal Antibody Diagnostic Reagents market are AnaSpec, BioGenex, Bio-Rad, Biocare Medical, BioVision, Celltrion, Creative Diagnostics, GenWay Biotech, Innovent Biologics, Medix Biochemica, Qiagen, and Teva Pharmaceutical Ltd. Antibodies are commonly used in research for ELISA, flow cytometric evaluation, immunoprecipitation, immunocytochemistry, immunohistochemistry, and western blotting, among other things. Monoclonal antibodies (MAbs) are essential diagnostic reagents used in physiological and microbial studies, as well as for the detection of chlamydia, hepatitis, herpes simplex, HIV, and influenza infections, as well as for the treatment of illnesses such as cancer. Diagnostic procedures that employ MAbs as chemicals are often used in laboratories in receptor immunosorbent assays and radioimmunoassays. Hormones (gastrin, testosterone, gonadotropin, blood sugar, progestin, pituitary gland, estrogen, progesterone, and renin) and cell products (gastrin, growth hormone, human chorionic gonadotropin, insulin, progesterone, thyroid stimulating hormone, thyroxine, triiodothyronine, and renin) and cell products. Monoclonal antibodies are useful in diagnosing diseases by determining the quantity of particular proteins in blood or urine. Prostate cancer can be detected early when a high blood level of a prostate-specific antigen interacts with a small molecule. Antibodies to particular biomarkers are commonly used to identify carcinogenic-embryonic antigen (colorectal cancer), prostate particular protein (present in prostate cancer), CA125 (ovarian cancer), CA19-9 (gastrointestinal cancer), CA15-3 antigen, and HER-2/neu proteins (breast cancer). What Monoclonal Antibody Diagnostic Reagents Market Research Report Covers? • This report covers definition, development, market status, geographical analysis of Monoclonal Antibody Diagnostic Reagents market. • Competitor analysis including all the key parameters of Monoclonal Antibody Diagnostic Reagents market • Market estimates for at least 7 years • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and proposals) • Strategic proposals in key business portions dependent available estimations • Company profiling with point by point systems, financials, and ongoing improvements • Mapping of the most recent innovative headways and Supply chain patterns Buy This Complete A Business Report With Flat US $2000 Off @ The global monoclonal antibody diagnostic reagents market is anticipated to expand due to the increasing usage of monoclonal antibodies in different R&D applications, cancer treatments, and immunological diseases. Monoclonal antibody diagnostic tests are becoming more widely utilized to diagnose infectious illnesses, such as transfusion-transmittable infections (TTI). As per the World Health Organization (WHO) estimates from 2017, around 15 million people die each year in emerging economies as a result of infectious illnesses. Morbidity is also caused by tropical parasite illnesses like schitosomiasis and sexually transmitted infections like syphilis. The availability of effective, accessible, and reliable measurement tools is critical. Globally, non-infectious illnesses are the main cause of death and morbidity. According to WHO estimates from 2017, about 40 million people worldwide die each year from cardiovascular illnesses, cancer, chronic respiratory diseases, diabetes, and stroke. The current rate of cancer incidence is projected to increase the need for illness diagnostics. As per the International Agency for Research on Cancer (IARC), cancer would be diagnosed in 26.8 million new cases and 17.1 million deaths per year by 2030. Due to their high accuracy in binding to numerous pathogens, monoclonal antibodies are useful biological reagents in immunodiagnostic tests, making them an essential research tool. 1.5 Global Monoclonal Antibody Diagnostic Reagents Market Size Analysis from 2021 to 2027 11.6 COVID-19 Outbreak: Monoclonal Antibody Diagnostic Reagents Industry Impact Chapter 2 Global Monoclonal Antibody Diagnostic Reagents Competition by Types, Applications, and Top Regions and Countries 2.1 Global Monoclonal Antibody Diagnostic Reagents (Volume and Value) by Type 2.3 Global Monoclonal Antibody Diagnostic Reagents (Volume and Value) by Regions Chapter 3 Production Market Analysis 3.1 Global Production Market Analysis 3.2 Regional Production Market Analysis Chapter 4 Global Monoclonal Antibody Diagnostic Reagents Sales, Consumption, Export, Import by Regions (2016-2021) Chapter 5 North America Monoclonal Antibody Diagnostic Reagents Market Analysis Chapter 6 East Asia Monoclonal Antibody Diagnostic Reagents Market Analysis Chapter 7 Europe Monoclonal Antibody Diagnostic Reagents Market Analysis Chapter 8 South Asia Monoclonal Antibody Diagnostic Reagents Market Analysis Chapter 9 Southeast Asia Monoclonal Antibody Diagnostic Reagents Market Analysis Chapter 10 Middle East Monoclonal Antibody Diagnostic Reagents Market Analysis Chapter 11 Africa Monoclonal Antibody Diagnostic Reagents Market Analysis Chapter 12 Oceania Monoclonal Antibody Diagnostic Reagents Market Analysis Chapter 13 South America Monoclonal Antibody Diagnostic Reagents Market Analysis Chapter 14 Company Profiles and Key Figures in Monoclonal Antibody Diagnostic Reagents Business Chapter 15 Global Monoclonal Antibody Diagnostic Reagents Market Forecast (2021-2027) Chapter 16 Conclusions Related Reports: Recombinant Human Endostatin Market , by Application (Medical Application, Scientific Application), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027 Recombinant Therapeutic Antibodies and Proteins Market , by Drug Class (Plasma Protein, Growth factors, Fusion Proteins, Monoclonal Antibodies, Hormones, Enzyme, Coagulation Factors, and Others), by Application (Oncology, Hematology, Immunology, Endocrinology, Infectious Disease, Cardiovascular Disease, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, trends, and Forecast to 2027 About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services. Contact:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing BioGenex

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BioGenex is included in 1 Expert Collection, including Health Monitoring & Diagnostics.

H

Health Monitoring & Diagnostics

76 items

Companies developing companion diagnostics and technology enabling the development of companion diagnostics. Tagged as #CompanionDx

BioGenex Patents

BioGenex has filed 5 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/3/2014

12/29/2020

Fluid dynamics, Fluid mechanics, Aerodynamics, Microarrays, Molecular biology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/3/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

12/29/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Fluid dynamics, Fluid mechanics, Aerodynamics, Microarrays, Molecular biology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

BioGenex Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

BioGenex Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.